Skip to content

Viral Vector Analytics

Smart polymers to power a new wave of analytical platforms

Current methods provide quick and useful indicators but are well known for overestimating the amount of virus present, and face challenges in complex sample compositions. We are operating at the intersection of chemistry and biology to design synthetic affinity reagents that bind exposed surface epitopes and easily integrate into our client’s technology and processes.

Why choose smart polymers?

Designed in silico.

  • Our pioneering computational chemistry means we can screen the full virus surface to identify optimally exposed epitopes and produce affinity reagents that are truly novel.
  • We have access to over 600 monomer building blocks (versus the traditional 20 amino acids) allowing us to build-in the exact functionality needed for the application.

Synthesized chemically.

  • The chemical manufacturing process of smart polymers means we can deliver a new wave of synthetic affinity reagents that go beyond the capabilities of biologics, providing safe, reproducible and scalable affinity solutions to our clients.
  • Smart polymers are free of Animal Derived Components (ADCs).

Deployed with confidence.

  • Smart polymers offer fresh solutions to solving high value bioprocessing challenges for our clients. We are using our technology to go beyond what is currently possible.
  • Large batch sizes, rapid scale up and manufacturing consistency means clients can depend on the smart polymer supply chain.

Want to learn more?

1509

VIDEO – A new approach to designing synthetic affinity…

Learn more
1463

Research

Novel synthetic affinity reagents for lentivirus analytics and capture…

Learn more
1433

NEWS

MIP Discovery rebrands as Tozaro as it completes transition…

Learn more
401

RESEARCH

Developing new tools for rapid quantification of viral vectors…

Learn more
406

NEWS

Tozaro closes £7M Series A financing to drive commercialization…

Learn more
408

NEWS

Tozaro (formally MIP Discovery) secures significant funding to support…

Learn more